In a TP53-mutated diffuse large B-cell lymphoma (DLBCL) PDX model, treatment with 50 mg/kg AF via oral gavage for 21 consecutive days also significantly inhibited tumor growth, without any body weight differences [14]. The gene discussed is TP53; the disease is neoplasm.